Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 17, 2024 20:39 ET | Source: Clinuvel Pharmaceuticals Limited

Afamelanotide in fair-skinned Parkinson’s patients

CLINUVEL has launch a novel clinical program evaluating afamelanotide as a treatment in early-stage Parkinson’s Disease in fair-skinned patients.
October 08, 2019 19:11 ET | Source: Clinuvel Pharmaceuticals Limited

FDA Approves SCENESSE® For Genetic Disorder

MELBOURNE, Australia, Oct. 08, 2019 (GLOBE NEWSWIRE) -- The US Food and Drug Administration (FDA) has approved a new drug as the first ever treatment for a rare genetic metabolic disorder which...
August 29, 2018 06:52 ET | Source: Clinuvel Pharmaceuticals Limited

CLINUVEL delivers second positive financial result

MELBOURNE, Australia, Aug. 29, 2018 (GLOBE NEWSWIRE) -- EXECUTIVE SUMMARY – FINANCIAL YEAR 01 JULY TO 30 JUNE 2017/182016/17ChangeTotal Revenues$25.750m$16.984m52%Net profit before income tax...
June 25, 2018 06:00 ET | Source: Clinuvel Pharmaceuticals Limited

FDA to Review Australian Drug for Genetic Disorder of Absolute Light Intolerance

MELBOURNE, Australia, June 25, 2018 (GLOBE NEWSWIRE) -- In a landmark case, the US Food and Drug Administration (FDA) has begun a review of an innovative drug developed for patients who carry a rare...
July 18, 2016 08:11 ET | Source: Clinuvel Pharmaceuticals Limited

Clinuvel to file new drug with FDA

MELBOURNE, Australia and NEW YORK, July 18, 2016 (GLOBE NEWSWIRE) -- Clinuvel Pharmaceuticals (ASX:CUV) (OTC:CLVLY) (XETRA:UR9) today announced that the US Food and Drug Administration (FDA) has...